PROTECT-1: A prospective randomized trial of CCX282-B (Traficet-EN), a novel oral therapy targeting chemokine receptor 9 in Crohn's disease

PROTECT-1: A prospective randomized trial of CCX282-B (Traficet-EN), a novel oral therapy targeting chemokine receptor 9 in Crohn's disease

Bibliographic Details
Main Authors:	Keshav, S, Petryka, R, Vanask, T, Niv, Y, Marlicz, K, Haagen-Nielsen, O, Machado, M, Dahlerup, J, Schreiber, S, Bekker, P, Sankar, S, Schall, T
Format:	Conference item
Published:	2007

Similar Items

Protect-1, a prospective randomized oral therapy evaluation of CCX282-B (Traficet-EN) in Crohn's disease trial
by: Bekker, P, et al.
Published: (2008)

Traficet-EN (CCX282-B), an orally active inhibitor of chemokine receptor CCR9, for treatment of Crohn's disease
by: Bekker, P, et al.
Published: (2007)

PROTECT-1 Maintenance Phase Study Results demonstrate efficacy of the Intestine-Specific Chemokine Receptor Antagonist CCX282-B (Traficet-EN) in Crohn's Disease
by: Bekker, P, et al.
Published: (2009)

PROTECT-1 Study Demonstrated Efficacy of the Intestine-Specific Chemokine Receptor Antagonist CCX282-B (Traficet-EN) in Treatment of Patients with Moderate to Severe Crohn's Disease
by: Keshav, S, et al.
Published: (2009)

A randomized controlled trial of the efficacy and safety of CCX282-B, an orally-administered blocker of chemokine receptor CCR9, for patients with Crohn's disease.
by: Satish Keshav, et al.
Published: (2013-01-01)

Ccx282-B, an orally active inhibitor of chemokine receptor Ccr9, shows anti-inflammatory and clinical activity in the treatment of Crohn's disease
by: Keshav, S, et al.
Published: (2007)

Characterization of CCX282-B, an orally bioavailable antagonist of the CCR9 chemokine receptor, for treatment of inflammatory bowel disease.
by: Walters, M, et al.
Published: (2010)

Traficet-EN, an oral CCR9-specific antagonist, induces high levels of remission in the open-label phase of PROTECT-1 in Crohn's disease
by: Bekker, P, et al.
Published: (2008)

Traficet-EN, an Oral CCR9-Specific Antagonist, induces high levels of remission in the open-label Phase of PROTECT-1 in Crohn's Disease
by: Bekker, P, et al.
Published: (2008)

MEDI 167-Discovery of the highly potent, selective and orally bioavailable CCR9 antagonist CCX282-B
by: Ungashe, S, et al.
Published: (2008)

Cc chemokine receptor 9 (ccr9) antagonist ameliorates experimental ileitis and colitis
by: Wei, Z, et al.
Published: (2005)

Identification and Expression Profiling Analysis of the Cation/Ca2+ Exchanger (CCX) Gene Family: Overexpression of SlCCX1-LIKE Regulates the Leaf Senescence in Tomato Flowering Phase
by: Jiao Li, et al.
Published: (2021-06-01)

Chemokines and myeloid cell recruitment.
by: Greaves, D, et al.
Published: (2000)

Therapeutic recommendations in HFE hemochromatosis for p.Cys282Tyr (C282Y/C282Y) homozygous genotype
by: Adams, P, et al.
Published: (2018)

A Node-Expressed Transporter OsCCX2 Is Involved in Grain Cadmium Accumulation of Rice
by: Xiaohua Hao, et al.
Published: (2018-04-01)

CCX559 is a potent, orally-administered small molecule PD-L1 inhibitor that induces anti-tumor immunity.
by: Kathleen M C Sullivan, et al.
Published: (2023-01-01)

Capsule endoscopy in the diagnosis of Crohn’s disease
by: Niv Y
Published: (2013-05-01)

Abduction of chemokine elements by herpesviruses
by: Dairaghi, D, et al.
Published: (1998)

Expression of CCR8 and CCX-CKR on Basophils in Chronic Urticaria Is Amplified by IgE-Mediated Activation
by: Ewa A. Bartko, et al.
Published: (2023-05-01)

Characterization of Pharmacologic and Pharmacokinetic Properties of CCX168, a Potent and Selective Orally Administered Complement 5a Receptor Inhibitor, Based on Preclinical Evaluation and Randomized Phase 1 Clinical Study.
by: Pirow Bekker, et al.
Published: (2016-01-01)

Editorial 28.2
by: Hormindo Pereira de Souza Junior, et al.
Published: (2019-09-01)

Correction: Characterization of Pharmacologic and Pharmacokinetic Properties of CCX168, a Potent and Selective Orally Administered Complement 5a Receptor Inhibitor, Based on Preclinical Evaluation and Randomized Phase 1 Clinical Study.
by: Pirow Bekker, et al.
Published: (2019-01-01)

Evidence for impaired CARD15 signalling in Crohn's disease without disease linked variants.
by: Jakob Benedict Seidelin, et al.
Published: (2009-11-01)

Complement activation capacity in plasma before and during high-dose prednisolone treatment and tapering in exacerbations of Crohn's disease and ulcerative colitis
by: Baatrup Gunnar, et al.
Published: (2005-09-01)

Pharmacological inhibition of CCR9 is a novel approach in the treatment of inflammatory bowel disease
by: Bekker, P, et al.
Published: (2007)

Medical management of Crohn's disease.
by: Cummings, JR, et al.
Published: (2008)

Emerging concepts in non-invasive monitoring of Crohn’s disease
by: Wojciech Marlicz, et al.
Published: (2018-04-01)

Mat 282- Pengiraan Kejuruteraan I
by: PPSM, Pusat Pengajian Sains Matematik
Published: (2004)

Contribuíram nesta edição (28.2)
Published: (2020-06-01)

Contribuíram nesta edição (28.2)
Published: (2020-06-01)

High-Pressure Cooling in Finishing Turning of Haynes 282 Using Carbide Tools: Haynes 282 and Inconel 718 Comparison
by: Antonio Díaz-Álvarez, et al.
Published: (2021-11-01)

282 COLPOSUSPENSION, DOES SUTURE MATERIAL MATTER?
by: S Kay, et al.
Published: (2022-06-01)

Dynamic strain aging in Haynes 282 superalloy
by: Hörnqvist Magnus, et al.
Published: (2014-01-01)

Community Connectors (CCx): the strategies employed by peer to peer connectors to foster relationships with early years caregivers to improve universal early child health and development
by: C. F. Mills, et al.
Published: (2021-03-01)

Draft genome sequence of the model naphthalene-utilizing organism Pseudomonas putida OUS282
by: Tay, Martin, et al.
Published: (2019)

ZAE 282/3 - SAINS BAHAN SEPT 1997.
by: PPSF, Pusat Pengajian Sains Fizik
Published: (1997)

ZAE282-3 - MATERIAL SCIENCES - NOVEMBER 2008.
by: PPSF, Pusat Pengajian Sains Fizik
Published: (2008)

MAT 282 - Engineering Computation I November 2006
by: PPSM, Pusat Pengajian Sains Matematik
Published: (2006)

MAT 282 - Pengiraan Kejuruteraan I - Oktober 2004
by: PPSM, Pusat Pengajian Sains Matematik
Published: (2004)

Genomic characteristics of an avipoxvirus 282E4 strain
by: Lingcong Deng, et al.
Published: (2023-10-01)